Federico et al found that consumption of antioxidants (303 mg silybin‐phospholipid complex, 10 mg vitamin D, and 15 mg vitamin E) twice daily for 6 months led to significant improvements in alanine transaminase (ALT) and gamma glutamyl transpeptidase (γGT) levels in patients with NAFLD compared to the healthy controls (Federico et al., 2019). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.